Whereas, most studies have demonstrated up-regulation of ANRIL in patients with CAD or animal models of CAD (20, 22), a single study has reported down-regulation of certain transcript of ANRIL in CAD coronary arteries as compared with samples obtained from non-CAD arteries (16). This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.